Kainos Medicine Inc (284620) — Strategic Asset Allocation Index
Kainos Medicine Inc (284620) has a Strategic Asset Allocation Index of 8.5% as of March 2025. Strategic assets (PP&E of ₩456.62 Million plus long-term investments of ₩-) total ₩456.62 Million, measured against net assets of ₩5.40 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Kainos Medicine Inc to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Kainos Medicine Inc Strategic Asset Allocation Index (2020–2024)
This chart shows how Kainos Medicine Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of March 2025, the index stands at 8.5%, representing strategic assets of ₩456.62 Million against net assets of ₩5.40 Billion KRW. For live market cap and overall valuation, see 284620 company net worth.
Annual Strategic Asset Allocation Index for Kainos Medicine Inc (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Kainos Medicine Inc from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Kainos Medicine Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 33.7% | ₩602.75 Million | ₩602.75 Million | ₩- | ₩1.79 Billion | ▲ +26.3 pp |
| 2023 | 7.5% | ₩875.47 Million | ₩875.47 Million | ₩- | ₩11.75 Billion | ▼ -13.4 pp |
| 2022 | 20.8% | ₩5.44 Billion | ₩5.44 Billion | ₩- | ₩26.11 Billion | ▼ -6.7 pp |
| 2021 | 27.5% | ₩3.33 Billion | ₩3.33 Billion | ₩- | ₩12.10 Billion | ▲ +12.6 pp |
| 2020 | 15.0% | ₩1.85 Billion | ₩1.85 Billion | ₩- | ₩12.35 Billion | — |